This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Abiomed
ABMD
$602.08
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
Earnings for Abiomed (ABMD)
Earnings in 2022 (TTM): A$0.49 Billion
According to Abiomed's latest financial reports the company's current earnings are A$1.07 Billion. In 2021 the company made an earning of A$0.29 Billion a decrease over its 2020 earnings that were of A$0.40 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Abiomed from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | A$0.49 B | 65.13% |
| 2021 | A$0.29 B | -25.49% |
| 2020 | A$0.40 B | -19.62% |
| 2019 | A$0.49 B | 48.14% |
| 2018 | A$0.33 B | 51% |
| 2017 | A$0.22 B | 71.85% |
| 2016 | A$0.12 B | 41.79% |
| 2015 | A$91.62 M | 187.69% |
| 2014 | A$31.84 M | 126.26% |
| 2013 | A$14.07 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | A$0.25 B | -53.39% | 🇺🇸 USA |
 | A$3.60 B | 568.89% | 🇺🇸 USA |
 | -A$58.89 Million | -110.92% | 🇺🇸 USA |